TY - JOUR
T1 - The combined use of Drug-eluting balloon and Excimer laser for coronary artery Restenosis In-Stent Treatment: The DERIST study
AU - Ambrosini, Vittorio
AU - Golino, Luca
AU - Niccoli, Giampaolo
AU - Roberto, Marco
AU - Lisanti, Pasquale
AU - Ceravolo, Roberto
AU - Bernardi, Guglielmo
AU - Armigliato, Pietro
AU - Gabrielli, Gabriele
AU - Chizzola, Giuliano
AU - De Paulis, Concetta
AU - Crea, Filippo
AU - Colombo, Antonio
PY - 2017
Y1 - 2017
N2 - Aim Stents reduce angiographic restenosis in comparison with balloon angioplasty. The rate of in-stent restenosis (ISR), although less frequent than post-angioplasty restenosis, is becoming increasingly prevalent due to the recent exponential increase in the use of intracoronary stents. The aim of this study is to evaluate angiographic and clinical outcomes of PTCA in combination with the use of excimer laser coronary angioplasty (ELCA) and drug-eluting balloon (DEB) in treatment of in-stent restenosis (ISR). Methods and results This multi-centric case-control study evaluated angiographic and clinical outcomes of PTCA with excimer laser coronary angioplasty (ELCA) and drug-eluting balloon (DEB) in 80 patients with in-stent restenosis (ISR). All patients underwent nine months of clinical and a coronary angiography follow-up. This study showed clinical and angiographic long-term success in the 91% of the patients. The incidence of myocardial infarctions and deaths was lower than the rate after plain balloon angioplasty within the stent. Conclusions This study showed that excimer laser coronary angioplasty (ELCA) and drug-eluting balloon (DEB) may be an alternative treatment for in-stent restenosis (ISR).
AB - Aim Stents reduce angiographic restenosis in comparison with balloon angioplasty. The rate of in-stent restenosis (ISR), although less frequent than post-angioplasty restenosis, is becoming increasingly prevalent due to the recent exponential increase in the use of intracoronary stents. The aim of this study is to evaluate angiographic and clinical outcomes of PTCA in combination with the use of excimer laser coronary angioplasty (ELCA) and drug-eluting balloon (DEB) in treatment of in-stent restenosis (ISR). Methods and results This multi-centric case-control study evaluated angiographic and clinical outcomes of PTCA with excimer laser coronary angioplasty (ELCA) and drug-eluting balloon (DEB) in 80 patients with in-stent restenosis (ISR). All patients underwent nine months of clinical and a coronary angiography follow-up. This study showed clinical and angiographic long-term success in the 91% of the patients. The incidence of myocardial infarctions and deaths was lower than the rate after plain balloon angioplasty within the stent. Conclusions This study showed that excimer laser coronary angioplasty (ELCA) and drug-eluting balloon (DEB) may be an alternative treatment for in-stent restenosis (ISR).
KW - Cardiology and Cardiovascular Medicine
KW - Drug Eluting Balloon (DEB)
KW - Excimer Laser Coronary Angioplasty (ELCA)
KW - In-stent restenosis (ISR)
KW - Cardiology and Cardiovascular Medicine
KW - Drug Eluting Balloon (DEB)
KW - Excimer Laser Coronary Angioplasty (ELCA)
KW - In-stent restenosis (ISR)
UR - http://hdl.handle.net/10807/98895
UR - http://www.elsevier.com/inca/publications/store/6/2/0/0/4/2
U2 - 10.1016/j.carrev.2016.12.012
DO - 10.1016/j.carrev.2016.12.012
M3 - Article
SN - 1553-8389
VL - 18
SP - 165
EP - 168
JO - Cardiovascular Revascularization Medicine
JF - Cardiovascular Revascularization Medicine
ER -